Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Weydt

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 9, 2025
"The DESCRIBE-ALS-FTD study: a prospective multicenter observational study of the ALS-FTD spectrum"Andreas Hermann, Johannes Prudlo, Elisabeth Kasper, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 22, 2025
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data captureLaura Steinfurth, Torsten Grehl, Ute Weyen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 13, 2024
<i>SOD1</i> gene screening in ALS - frequency of mutations, patients' attitudes to genetic information and transition to tofersen treatment in a multi-center programThomas Meyer, Peggy Schumann, Torsten Grehl, et al.
Annals of Neurology|May 11, 2026
Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral SclerosisElisabeth Kasper, Annaliis Lehto, Alexandra Jürs, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 11, 2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter studySusanne Spittel, Torsten Grehl, Patrick Weydt, et al.
Neurology|December 8, 2017
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosisEmily Feneberg, Patrick Oeckl, Petra Steinacker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2018
Comprehensive analysis of the mutation spectrum in 301 German ALS familiesKathrin Müller, David Brenner, Patrick Weydt, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 12, 2021
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter studyPetra Steinacker, Emily Feneberg, Steffen Halbgebauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progressionPetra Steinacker, Federico Verde, Lubin Fang, et al.
European Journal of Neurology|June 11, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter studyThomas Meyer, Marie Dreger, Torsten Grehl, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 9, 2025
"The DESCRIBE-ALS-FTD study: a prospective multicenter observational study of the ALS-FTD spectrum"Andreas Hermann, Johannes Prudlo, Elisabeth Kasper, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 22, 2025
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data captureLaura Steinfurth, Torsten Grehl, Ute Weyen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 13, 2024
<i>SOD1</i> gene screening in ALS - frequency of mutations, patients' attitudes to genetic information and transition to tofersen treatment in a multi-center programThomas Meyer, Peggy Schumann, Torsten Grehl, et al.
Annals of Neurology|May 11, 2026
Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral SclerosisElisabeth Kasper, Annaliis Lehto, Alexandra Jürs, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 11, 2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter studySusanne Spittel, Torsten Grehl, Patrick Weydt, et al.
Neurology|December 8, 2017
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosisEmily Feneberg, Patrick Oeckl, Petra Steinacker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2018
Comprehensive analysis of the mutation spectrum in 301 German ALS familiesKathrin Müller, David Brenner, Patrick Weydt, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 12, 2021
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter studyPetra Steinacker, Emily Feneberg, Steffen Halbgebauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progressionPetra Steinacker, Federico Verde, Lubin Fang, et al.
European Journal of Neurology|June 11, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter studyThomas Meyer, Marie Dreger, Torsten Grehl, et al.
Pageof 11